Wells Fargo & Company Cuts Omnicell (NASDAQ:OMCL) Price Target to $40.00

Omnicell (NASDAQ:OMCL) had its price objective reduced by Wells Fargo & Company from $49.00 to $40.00 in a report released on Monday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

A number of other research firms have also recently commented on OMCL. Craig Hallum lifted their price target on shares of Omnicell from $45.00 to $64.00 and gave the stock a “buy” rating in a research note on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and set a $48.00 price target on shares of Omnicell in a research note on Wednesday, October 9th. StockNews.com cut shares of Omnicell from a “buy” rating to a “hold” rating in a research note on Tuesday, December 10th. Bank of America dropped their price target on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a research note on Monday, January 6th. Finally, Barclays lifted their price target on shares of Omnicell from $39.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $50.00.

Omnicell Stock Up 1.9 %

Shares of NASDAQ:OMCL opened at $43.13 on Monday. Omnicell has a 52 week low of $25.12 and a 52 week high of $55.74. The stock has a market capitalization of $2.00 billion, a P/E ratio of -110.59, a PEG ratio of 34.96 and a beta of 0.78. The firm has a fifty day simple moving average of $45.42 and a two-hundred day simple moving average of $41.45.

Insider Buying and Selling at Omnicell

In other Omnicell news, Director Mark W. Parrish sold 12,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $47.30, for a total value of $567,600.00. Following the completion of the sale, the director now directly owns 58,427 shares of the company’s stock, valued at $2,763,597.10. The trade was a 17.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.64% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Omnicell

Several large investors have recently modified their holdings of OMCL. Rhumbline Advisers raised its holdings in shares of Omnicell by 3.0% in the 2nd quarter. Rhumbline Advisers now owns 147,188 shares of the company’s stock valued at $3,984,000 after purchasing an additional 4,281 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Omnicell by 2.9% in the 2nd quarter. Arizona State Retirement System now owns 12,853 shares of the company’s stock valued at $348,000 after purchasing an additional 357 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Omnicell in the 2nd quarter valued at about $104,000. Federated Hermes Inc. raised its holdings in shares of Omnicell by 1,113.6% in the 2nd quarter. Federated Hermes Inc. now owns 991,151 shares of the company’s stock valued at $26,830,000 after purchasing an additional 909,480 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Omnicell by 0.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,180,503 shares of the company’s stock valued at $31,955,000 after purchasing an additional 3,570 shares in the last quarter. Institutional investors own 97.70% of the company’s stock.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.